{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:40:49Z","timestamp":1791247249619,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of Institute of Chinese Medicine, Nanjing University","award":["Funding Number: ICM2024010"],"award-info":[{"award-number":["Funding Number: ICM2024010"]}]},{"name":"Aid Project of Jiangsu Ningai Medical Development & Medical Aid Foundation","award":["Funding Number: NDYGN2024026"],"award-info":[{"award-number":["Funding Number: NDYGN2024026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01126-y","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:03:41Z","timestamp":1775225021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["iRGD-functionalized PLGA nanocomplex co-loaded with paclitaxel and Trametes robiniophila Murr for targeted inhibition of chemoresistant and metastatic signaling gene PDCD4 in colon cancer"],"prefix":"10.1186","volume":"27","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Shuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"crossref","unstructured":"Sung H et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3): 209\u201349.","DOI":"10.3322\/caac.21660"},{"key":"1126_CR2","doi-asserted-by":"crossref","unstructured":"Patel V, Rajak H. Advances in chemoradiotherapy for treatment of colon cancer. In: Colon cancer diagnosis and therapy. Vol. 3. Springer; 2022. p. 217\u2013239.","DOI":"10.1007\/978-3-030-72702-4_11"},{"key":"1126_CR3","doi-asserted-by":"crossref","unstructured":"Cervantes A, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332.","DOI":"10.1016\/j.annonc.2022.10.003"},{"issue":"1","key":"1126_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40001-024-01657-2","volume":"29","author":"P Sati","year":"2024","unstructured":"Sati P, et al. Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties. Eur J Med Res. 2024;29(1):90.","journal-title":"Eur J Med Res"},{"key":"1126_CR5","doi-asserted-by":"crossref","unstructured":"Krasteva N, Georgieva M. Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials. Pharmaceutics. 2022;14(6):1213.","DOI":"10.3390\/pharmaceutics14061213"},{"issue":"8","key":"1126_CR6","doi-asserted-by":"publisher","first-page":"e5107","DOI":"10.1002\/bmc.5107","volume":"35","author":"Y Fei","year":"2021","unstructured":"Fei Y, Wang Y, Wu S, Shen F, Fan G. Evaluation of the efficacy and safety of a new formulation-lipid emulsion\u2010based PTX injection: Pharmacokinetics, tissue distributions and anticancer effect on human gastric cancer cells in vitro. Biomed Chromatogr. 2021;35(8):e5107.","journal-title":"Biomed Chromatogr"},{"issue":"6","key":"1126_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40005-022-00584-w","volume":"52","author":"A Zeb","year":"2022","unstructured":"Zeb A, Gul M, Nguyen T-T-L, Maeng H-J. Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: reviewing two decades of research. J Pharm Invest. 2022;52(6):683\u2013724.","journal-title":"J Pharm Invest"},{"key":"1126_CR8","doi-asserted-by":"publisher","unstructured":"Sun R, et al. The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers. Heliyon. 2024;10(18):e38165. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38165.","DOI":"10.1016\/j.heliyon.2024.e38165"},{"key":"1126_CR9","doi-asserted-by":"crossref","unstructured":"Sharifi M, et al. An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment. Cancers. 2022;14(12):2868.","DOI":"10.3390\/cancers14122868"},{"key":"1126_CR10","doi-asserted-by":"crossref","unstructured":"Nikitovic D, et al. Enhancing tumor targeted therapy: the role of iRGD peptide in advanced drug delivery systems. Cancers. 2024;16(22):3768.","DOI":"10.3390\/cancers16223768"},{"key":"1126_CR11","doi-asserted-by":"publisher","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293. https:\/\/doi.org\/10.1038\/s41392-023-01536-y.","DOI":"10.1038\/s41392-023-01536-y"},{"key":"1126_CR12","doi-asserted-by":"publisher","unstructured":"Thirumalai A, Girigoswami K, Pallavi P, Harini K, Gowtham P, Girigoswami A. Cancer therapy with iRGD as a tumor-penetrating peptide. Bull Cancer. 2023;110(12):1288\u20131300. https:\/\/doi.org\/10.1016\/j.bulcan.2023.08.009.","DOI":"10.1016\/j.bulcan.2023.08.009"},{"key":"1126_CR13","doi-asserted-by":"crossref","unstructured":"Zhong Y et al. Co-administration of iRGD enhances tumor-targeted delivery and anti-tumor effects of paclitaxel-loaded PLGA nanoparticles for colorectal cancer treatment. Int J Nanomed. 2019;14:8543\u201360.","DOI":"10.2147\/IJN.S219820"},{"key":"1126_CR14","doi-asserted-by":"crossref","unstructured":"Yap KM et al. Drug delivery of natural products through nanocarriers for effective breast cancer therapy: a comprehensive review of literature. Int J Nanomed, pp. 7891\u2013941, 2021.","DOI":"10.2147\/IJN.S328135"},{"key":"1126_CR15","doi-asserted-by":"publisher","unstructured":"Pan J, Yang C, Jiang Z, Huang J. Trametes robiniophila Murr: a traditional Chinese medicine with potent anti-tumor effects, (in eng). Cancer Manag Res. 2019;11:1541\u20139. https:\/\/doi.org\/10.2147\/cmar.S193174","DOI":"10.2147\/cmar.S193174"},{"key":"1126_CR16","doi-asserted-by":"publisher","unstructured":"Zang Y, Qiu Y, Sun Y, Fan Y. Immunomodulatory effects of Huaier granule in cancer therapy: a meta-analysis of randomized controlled trials, (in eng). Eur J Med Res. 2024;29(1):467 https:\/\/doi.org\/10.1186\/s40001-024-02060-7.","DOI":"10.1186\/s40001-024-02060-7"},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"e24017","DOI":"10.53388\/2024724017","volume":"7","author":"H Cao","year":"2024","unstructured":"Cao H, Wu C, Xian X. Research progress on Chinese herbal drugs in the TGF-\u03b2 signaling pathway involved in epithelial-mesenchymal transition. Cancer Adv. 2024;7:e24017.","journal-title":"Cancer Adv"},{"key":"1126_CR18","doi-asserted-by":"publisher","first-page":"153473542210839","DOI":"10.1177\/15347354221083910","volume":"21","author":"J Chen","year":"2022","unstructured":"Chen J, Chen S, Zhou Y, Wang S, Wu W. Efficacy and safety of huaier granule as an adjuvant therapy for cancer: an overview of systematic reviews and meta-analyses. Integr Cancer Ther. 2022;21:15347354221083910.","journal-title":"Integr Cancer Ther"},{"key":"1126_CR19","doi-asserted-by":"publisher","unstructured":"Kang S, Lee S, Park S. iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery. Polymers (Basel). 2020;12(9). https:\/\/doi.org\/10.3390\/polym12091906.","DOI":"10.3390\/polym12091906"},{"key":"1126_CR20","doi-asserted-by":"publisher","first-page":"1670397","DOI":"10.3389\/fphar.2025.1670397","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Tao T, Xiong Y, Guo W, Liang Y. Multifunctional PLGA nanosystems: enabling integrated diagnostic and therapeutic strategies. Front Pharmacol. 2025;16:1670397.","journal-title":"Front Pharmacol"},{"key":"1126_CR21","doi-asserted-by":"crossref","unstructured":"Sanz-Pamplona R, et al. Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer. Mol Cancer. 2014;13(1):46.","DOI":"10.1186\/1476-4598-13-46"},{"issue":"7","key":"1126_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u201347.","journal-title":"Nucleic Acids Res"},{"key":"1126_CR23","doi-asserted-by":"crossref","unstructured":"Lusby R, et al. Pan-cancer drivers of metastasis. Mol Cancer. 2025;24(1):2.","DOI":"10.1186\/s12943-024-02182-w"},{"issue":"2","key":"1126_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/tpj.2014.45","volume":"15","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Zhou J, Tong Y. Gene signatures of drug resistance predict patient survival in colorectal cancer. Pharmacogenomics J. 2015;15(2):135\u201343.","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"1126_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"Cv Mering","year":"2003","unstructured":"Mering Cv, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258\u201361.","journal-title":"Nucleic Acids Res"},{"key":"1126_CR26","doi-asserted-by":"crossref","unstructured":"Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics. 2005;21(16):3448\u20139.","DOI":"10.1093\/bioinformatics\/bti551"},{"key":"1126_CR27","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3(2):180\u20135.","DOI":"10.1002\/wics.147"},{"key":"1126_CR28","doi-asserted-by":"crossref","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5(3).","DOI":"10.1016\/j.xinn.2024.100625"},{"key":"1126_CR29","doi-asserted-by":"crossref","unstructured":"Tsai CA, Hsueh HM, Chen JJ. Estimation of false discovery rates in multiple testing: application to gene microarray data. Biometrics. 2003;59(4):1071\u201381.","DOI":"10.1111\/j.0006-341X.2003.00123.x"},{"issue":"1","key":"1126_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13321-016-0163-1","volume":"8","author":"S Kim","year":"2016","unstructured":"Kim S, Bolton EE, Bryant SH. Similar compounds versus similar conformers: complementarity between PubChem 2-D and 3-D neighboring sets. J Cheminform. 2016;8(1):62.","journal-title":"J Cheminform"},{"key":"1126_CR31","doi-asserted-by":"crossref","unstructured":"Kim S. Exploring chemical information in PubChem. Curr Protoc. 2021;1(8):e217.","DOI":"10.1002\/cpz1.217"},{"issue":"1","key":"1126_CR32","doi-asserted-by":"publisher","first-page":"e70006","DOI":"10.1002\/pro.70006","volume":"34","author":"S Francisco","year":"2025","unstructured":"Francisco S, Lamacchia L, Turco A, Ermondi G, Caron G, Rossi Sebastiano M. Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50. Protein Sci. 2025;34(1):e70006.","journal-title":"Protein Sci"},{"issue":"W1","key":"1126_CR33","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1126_CR34","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1021\/acs.jmedchem.1c00416","volume":"64","author":"PD Leeson","year":"2021","unstructured":"Leeson PD, et al. Target-based evaluation of drug-like properties and ligand efficiencies. J Med Chem. 2021;64(11):7210\u201330.","journal-title":"J Med Chem"},{"issue":"4","key":"1126_CR35","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.21037\/jgo-21-415","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Luo A, Zeng Z, Zhou Y, Wu W. Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis. J Gastrointest Oncol. 2021;12(4):1613.","journal-title":"J Gastrointest Oncol"},{"key":"1126_CR36","doi-asserted-by":"crossref","unstructured":"Zhou S, et al. Expression profilings of 39 genes selected by ANOVA could separate precursors of murine dendritic cells and macrophages. Biochem Biophys Res Commun. 2006;344(1):438\u201345.","DOI":"10.1016\/j.bbrc.2006.03.125"},{"key":"1126_CR37","doi-asserted-by":"crossref","unstructured":"Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","DOI":"10.1126\/scisignal.2004088"},{"key":"1126_CR38","doi-asserted-by":"publisher","first-page":"e24016","DOI":"10.53388\/2024724016","volume":"7","author":"W Fu","year":"2024","unstructured":"Fu W, Wang Y, Yan Q, Cheng G, Lyu L, Ding Y. Prognostic significance of CDKN2A expression in colon adenocarcinoma: insights from TCGA analysis. Cancer Adv. 2024;7:e24016.","journal-title":"Cancer Adv"},{"issue":"1","key":"1126_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12864-021-07581-7","volume":"22","author":"Y Li","year":"2021","unstructured":"Li Y, Umbach DM, Krahn JM, Shats I, Li X, Li L. Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines. BMC Genomics. 2021;22(1):272.","journal-title":"BMC Genomics"},{"issue":"2","key":"1126_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.64123\/mijm.v1.i2.3","volume":"1","author":"F Prasetyawan","year":"2025","unstructured":"Prasetyawan F, Saristiana Y, Mildawati R, Rhomah EH, Fadel MN, Besan EJ. Pharmacokinetics and Druglikeness of Amoxicillin Drug using SwissADME. Multicore Int J Multidisciplinary (MIJM). 2025;1(2):67\u201375.","journal-title":"Multicore Int J Multidisciplinary (MIJM)"},{"issue":"W1","key":"1126_CR41","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkae254","volume":"52","author":"Y Myung","year":"2024","unstructured":"Myung Y, de S\u00e1 AG, Ascher DB. Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res. 2024;52(W1):W469\u201375.","journal-title":"Nucleic Acids Res"},{"key":"1126_CR42","doi-asserted-by":"crossref","unstructured":"C\u00e1ceres EL, Tudor M, Cheng AC. Deep learning approaches in predicting ADMET properties. Future Med Chem. 2020;12(22):1995\u20139.","DOI":"10.4155\/fmc-2020-0259"},{"key":"1126_CR43","doi-asserted-by":"crossref","unstructured":"Burley SK; RCSB Protein Data Bank. Celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D. Protein Sci. 2022;31(1):187\u2013208.","DOI":"10.1002\/pro.4213"},{"key":"1126_CR44","doi-asserted-by":"crossref","unstructured":"Meng EC, et al. UCSF ChimeraX: Tools for structure building and analysis. Protein Sci. 2023;32(11):e4792.","DOI":"10.1002\/pro.4792"},{"issue":"2","key":"1126_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, et al. The ClusPro web server for protein\u2013protein docking. Nat Protoc. 2017;12(2):255\u201378.","journal-title":"Nat Protoc"},{"key":"1126_CR46","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao Z-X, Cao Y. CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50(W1):W159\u201364.","DOI":"10.1093\/nar\/gkac394"},{"key":"1126_CR47","doi-asserted-by":"crossref","unstructured":"Aaltonen JE. gmx_ffconv: A fast, user-friendly semi-automated all-atom force field converter for GROMACS. J Chem Inf Model. 2025.","DOI":"10.1021\/acs.jcim.5c02200"},{"issue":"1","key":"1126_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3126\/jnphyssoc.v9i1.57599","volume":"9","author":"P Yadav","year":"2023","unstructured":"Yadav P, Lamichhane T. Analysis of Force Fields of Drug-like Molecules: Omeprazole, Favipiravir and Amoxicillin by Using Bonded and Non-bonded Potential Distributions. J Nepal Phys Soc. 2023;9(1):58\u201372.","journal-title":"J Nepal Phys Soc"},{"key":"1126_CR49","doi-asserted-by":"publisher","first-page":"120116","DOI":"10.1016\/j.molliq.2022.120116","volume":"365","author":"Q Ke","year":"2022","unstructured":"Ke Q, Gong X, Liao S, Duan C, Li L. Effects of thermostats\/barostats on physical properties of liquids by molecular dynamics simulations. J Mol Liq. 2022;365:120116.","journal-title":"J Mol Liq"},{"issue":"3","key":"1126_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.critrevonc.2009.09.001","volume":"73","author":"H Allgayer","year":"2010","unstructured":"Allgayer H. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol\/Hematol. 2010;73(3):185\u201391.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"1126_CR51","doi-asserted-by":"crossref","unstructured":"Lim SC, Hong R. Programmed cell death 4 (Pdcd4) expression in colorectal adenocarcinoma: Association with clinical stage. Oncol Lett. 2011;2(6):1053\u20137.","DOI":"10.3892\/ol.2011.365"},{"key":"1126_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2018.09.034","volume":"680","author":"J Long","year":"2019","unstructured":"Long J, et al. The mechanisms and clinical significance of PDCD4 in colorectal cancer. Gene. 2019;680:59\u201364.","journal-title":"Gene"},{"key":"1126_CR53","doi-asserted-by":"publisher","first-page":"903374","DOI":"10.3389\/fonc.2022.903374","volume":"12","author":"WF Ferris","year":"2022","unstructured":"Ferris WF. The role and interactions of programmed cell death 4 and its regulation by microRNA in transformed cells of the gastrointestinal tract. Front Oncol. 2022;12:903374.","journal-title":"Front Oncol"},{"key":"1126_CR54","doi-asserted-by":"crossref","unstructured":"Ogawa K, et al. A 10-year observational study of the effects of serum 25OH vitamin D levels on the onset of prediabetes at a preventive medicine research center. Endocr J. 2025:EJ25\u20130007.","DOI":"10.1507\/endocrj.EJ25-0007"},{"key":"1126_CR55","doi-asserted-by":"crossref","unstructured":"Li Y, Wei J, Xu C, Zhao Z, You T. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies. PLoS One. 2014;9(4):e94508.","DOI":"10.1371\/journal.pone.0094508"},{"issue":"13","key":"1126_CR56","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1158\/1078-0432.CCR-08-3330","volume":"15","author":"S Ogino","year":"2009","unstructured":"Ogino S, et al. A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Clin Cancer Res. 2009;15(13):4431\u20138.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1126_CR57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/jcm12020572","volume":"12","author":"S-Y Jun","year":"2023","unstructured":"Jun S-Y, Kim J, Yoon N, Maeng L-S, Byun JH. Prognostic potential of cyclin D1 expression in colorectal cancer. J Clin Med. 2023;12(2):572.","journal-title":"J Clin Med"},{"key":"1126_CR58","doi-asserted-by":"crossref","unstructured":"Farhat N, Khan AU. Inhibitors against New Delhi metallo-betalactamase-1 (NDM-1) and its variants endemic in Indian settings along with the laboratory functional gain mutant of NDM-1. Eur J Clin Microbiol Infect Dis. 2024:1\u201320.","DOI":"10.1007\/s10096-024-04761-7"},{"key":"1126_CR59","doi-asserted-by":"crossref","unstructured":"Kang S, Lee S, Park S. iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery. Polymers (Basel). 2020;12(9):1906.","DOI":"10.3390\/polym12091906"},{"key":"1126_CR60","doi-asserted-by":"crossref","unstructured":"Zuo HD, et al. The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study. Biomed Res Int. 2014;2014:852352.","DOI":"10.1155\/2014\/852352"},{"issue":"1","key":"1126_CR61","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1093\/cid\/ciab942","volume":"75","author":"ZJ Li","year":"2022","unstructured":"Li ZJ, et al. Broad impacts of coronavirus disease 2019 (COVID-19) pandemic on acute respiratory infections in China: an observational study. Clin Infect Dis. 2022;75(1):e1054\u201362.","journal-title":"Clin Infect Dis"},{"key":"1126_CR62","doi-asserted-by":"crossref","unstructured":"Li L, Yang M, Li R, Hu J, Yu L, Qian X. iRGD co-administration with paclitaxel-loaded PLGA nanoparticles enhance targeting and antitumor effect in colorectal cancer treatment. Anti-Cancer Agents Med Chem. 2021;21(7):910\u20138.","DOI":"10.2174\/1871520620666200721134919"},{"issue":"11","key":"1126_CR63","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1016\/j.cpc.2014.06.019","volume":"185","author":"C Paissoni","year":"2014","unstructured":"Paissoni C, Spiliotopoulos D, Musco G, Spitaleri A. GMXPBSA 2.0: A GROMACS tool to perform MM\/PBSA and computational alanine scanning. Comput Phys Commun. 2014;185(11):2920\u20139.","journal-title":"Comput Phys Commun"},{"key":"1126_CR64","doi-asserted-by":"crossref","unstructured":"Yan F, et al. A lipopeptide-based \u03b1v\u03b23 integrin-targeted ultrasound contrast agent for molecular imaging of tumor angiogenesis. Ultrasound Med Biol. 2015;41(10):2765\u201373.","DOI":"10.1016\/j.ultrasmedbio.2015.05.023"},{"key":"1126_CR65","doi-asserted-by":"crossref","unstructured":"Saifi MA, Sathish G, Bazaz MR, Godugu C. Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188895.","DOI":"10.1016\/j.bbcan.2023.188895"},{"issue":"7","key":"1126_CR66","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejso.2011.04.001","volume":"37","author":"K Chang","year":"2011","unstructured":"Chang K, et al. MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol (EJSO). 2011;37(7):597\u2013603.","journal-title":"Eur J Surg Oncol (EJSO)"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01126-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01126-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:41:17Z","timestamp":1778715677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01126-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01126-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}